APU
LLY icon

Alpine Partners USVI’s Eli Lilly LLY Stock Holding History

Alpine Partners USVI’s Portfolio LLY Stock Details LLY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2013
Q3 		– Sell
-19,186
Closed -$942K – 91
2013
Q2 		$942K Buy
+19,186
New +$1.04M 0.31% 51

Other funds holding LLY

Lilly Endowment
Lilly Endowment Indiananapolis, Indiana $84.5B AUM 11.36% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
State Farm Mutual Automobile Insurance
State Farm Mutual Automobile Insurance Bloomington, Illinois $127B AUM 32.55% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Alpine Partners USVI's LLY Position: Q3 2013 in Review

Alpine Partners USVI sold out of Eli Lilly (LLY) in Q3 2013, closing a stake of 19,186 shares — an estimated $942K sold.

Alpine Partners USVI first reported a position in LLY in Q2 2013 and held it in 1 quarter. The position peaked at $942K in Q2 2013. 973 funds tracked by Wall St. Rank hold LLY as of Q3 2013.

  • Alpine Partners USVI reported no remaining Eli Lilly position as of Q3 2013 after selling out during the quarter.
  • Alpine Partners USVI sold 19,186 Eli Lilly shares in Q3 2013, an estimated $942K.
  • Alpine Partners USVI first reported a position in Eli Lilly in Q2 2013 and held it in 1 quarter.
  • Alpine Partners USVI's Eli Lilly position peaked at $942K in Q2 2013.
  • 973 funds tracked by Wall St. Rank held Eli Lilly as of Q3 2013.

Based on Alpine Partners USVI's 13F filing for Q3 2013, filed 14 Nov 2013.